TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial.

Martin Hutchings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.